Document Detail

Predicting dropout in the first 3 months of 12-step residential drug and alcohol treatment in an Australian sample.
MedLine Citation:
PMID:  22333329     Owner:  NLM     Status:  In-Data-Review    
ABSTRACT. Objective: Premature termination from treatment is a major factor associated with poorer drug and alcohol treatment outcomes. The present study investigated client-related baseline predictors of dropout at 3 months from a faith-based 12-step residential drug treatment program. Method: Data were collected over a period of 14 months from eight residential drug and alcohol treatment programs run by The Australian Salvation Army. The final sample consisted of 618 participants, including 524 men (84.8%) and 94 women (15.2%). Predictor variables of interest were age, gender, primary drug of concern, criminal involvement, psychological distress, drug cravings, self-efficacy to abstain, spirituality, forgiveness of self and others, and life purpose. At 3 months, 264 participants (42.7%) remained in the treatment program, and 354 participants (57.3%) had dropped out. Results: Binary logistic regression revealed that individuals were more likely to drop out by the 3-month time frame if at intake their primary drug of concern was a drug other than alcohol or they reported greater forgiveness of self. Conclusions: To the authors' knowledge, this is the first study to examine forgiveness as a predictor of dropout from a drug treatment program. Assessing patient's primary drug of concern and levels of forgiveness may be useful for residential drug treatment providers in constructing programs that provide differential treatment based on the results of these assessments. (J. Stud. Alcohol Drugs, 73, 216-225, 2012).
Frank P Deane; David J Wootton; Ching-I Hsu; Peter J Kelly
Related Documents :
9669789 - Life-threatening interaction of mibefradil and beta-blockers with dihydropyridine calci...
22315269 - Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed...
17686379 - Renin inhibition: a new modality for hypertension management.
22735239 - Fabrication of magnetic nanoparticles with controllable drug loading and release throug...
22484149 - Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailabi...
22529489 - Phenytoin in treatment of amiodarone-induced torsades de pointes.
15198509 - Development and characterization of a recombinant madin-darby canine kidney cell line t...
20486729 - A decade of safety-related regulatory action in the netherlands: a retrospective analys...
2872689 - Cellular effects of cannabinoids.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of studies on alcohol and drugs     Volume:  73     ISSN:  1938-4114     ISO Abbreviation:  J Stud Alcohol Drugs     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-02-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101295847     Medline TA:  J Stud Alcohol Drugs     Country:  United States    
Other Details:
Languages:  eng     Pagination:  216-25     Citation Subset:  IM    
School of Psychology and Illawarra Institute for Mental Health, University of Wollongong, Wollongong, NSW 2522, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of alcohol availability, access to alcohol, and naltrexone on self-reported craving and patt...
Next Document:  Cost-effectiveness analysis of motivational interviewing with feedback to reduce drinking among a sa...